CN1908003A - Method of synthesizing 9 alpha-bromine-11 beta-hydroxypregna-1,4,16-triene-3,20-diketone - Google Patents
Method of synthesizing 9 alpha-bromine-11 beta-hydroxypregna-1,4,16-triene-3,20-diketone Download PDFInfo
- Publication number
- CN1908003A CN1908003A CN 200610052956 CN200610052956A CN1908003A CN 1908003 A CN1908003 A CN 1908003A CN 200610052956 CN200610052956 CN 200610052956 CN 200610052956 A CN200610052956 A CN 200610052956A CN 1908003 A CN1908003 A CN 1908003A
- Authority
- CN
- China
- Prior art keywords
- bromo
- triene
- hydroxypregna
- dione
- diketone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Steroid Compounds (AREA)
Abstract
9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮合成法为医药化学领域。以孕甾-1,4,9(11),16-四烯-3,20-二酮为原料,在N-溴代酰胺、有机溶剂、高氯酸存在下,保留分子中的1,4,16位双键,选择性地对9(11)位双键进行羟溴化合成甾体化合物9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮。本发明合成的甾体化合物9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮未见国内外文献报道,为新化合物。所合成的步骤简单,反应条件温和,操作简便,收率高。The synthesis method of 9α-bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione belongs to the field of medicinal chemistry. Using pregnane-1,4,9(11),16-tetraene-3,20-dione as raw material, in the presence of N-bromoamide, organic solvent and perchloric acid, retain 1,4 in the molecule , 16-position double bond, selective hydroxybromination of 9(11)-position double bond to synthesize steroidal compound 9α-bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione . The steroidal compound 9α-bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione synthesized by the invention has no domestic and foreign literature reports, and is a new compound. The synthesis steps are simple, the reaction conditions are mild, the operation is simple and the yield is high.
Description
技术领域technical field
本发明属于化学技术领域,涉及药物合成,具体为一种甾体抗炎药瑞美松龙(Rimexolone)的中间体9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮的合成法。The invention belongs to the field of chemical technology, and relates to drug synthesis, specifically a steroidal anti-inflammatory drug Rimexolone intermediate 9α-bromo-11β-hydroxypregna-1,4,16-triene-3 , Synthesis of 20-diketones.
背景技术Background technique
11β-羟基孕甾-1,4,16-三烯-3,20-二酮(化合物3)是合成甾体抗炎药瑞美松龙(Rimexolone)的中间体,瑞美松龙具有抗炎、抗过敏功效高,副作用小,长期使用不会造成眼内压升高等优点,是目前唯一安全的眼科甾体抗炎药物。11β-羟基孕甾-1,4,16-三烯-3,20-二酮可以通过9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮(化合物2)脱溴后得到。11β-hydroxypregna-1,4,16-triene-3,20-dione (compound 3) is an intermediate in the synthesis of the steroidal anti-inflammatory drug Rimexolone, which has anti-inflammatory properties , High anti-allergic effect, less side effects, long-term use will not cause intraocular pressure to rise, etc. It is the only safe ophthalmic steroidal anti-inflammatory drug at present. 11β-hydroxypregna-1,4,16-triene-3,20-dione can pass through 9α-bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione (compound 2) Obtained after debromination.
本发明的目的是发明一种合成9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮的方法。The object of the present invention is to invent a method for synthesizing 9α-bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione.
发明内容Contents of the invention
我们以合成地塞米松的中间体孕甾-1,4,9(11),16-三烯-3,20-二酮(化合物1)为原料,在N-溴代酰胺、有机溶剂、高氯酸存在下,保留分子中的1,4,16位双键,选择性地对9(11)位双键进行羟溴化合成9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮。We use the intermediate pregnane-1,4,9(11),16-triene-3,20-dione (compound 1) as raw material for the synthesis of dexamethasone in N-bromoamide, organic solvent, high In the presence of chloric acid, the 1, 4, 16 double bonds in the molecule are retained, and the 9 (11) double bonds are selectively hydroxybrominated to synthesize 9α-bromo-11β-hydroxypregna-1,4,16- Triene-3,20-dione.
上述N-溴代酰胺指N-溴代丁二酰亚胺,N-溴代乙酰胺其一。The aforementioned N-bromoamide refers to N-bromosuccinimide, one of N-bromoacetamides.
上述有机溶剂指四氢呋喃,二氧六环其一。The above-mentioned organic solvent refers to tetrahydrofuran, one of dioxane.
本发明合成的甾体化合物9α-溴-11β-羟基孕甾-1,4,16-三烯-3,20-二酮未见国内外文献报道,为新化合物。所合成的步骤简单,反应条件温和,操作简便,收率高。The steroidal compound 9α-bromo-11β-hydroxypregna-1,4,16-triene-3,20-dione synthesized by the present invention has no domestic and foreign literature reports, and is a new compound. The synthesis steps are simple, the reaction conditions are mild, the operation is simple and the yield is high.
具体实施方式Detailed ways
例1example 1
在反应瓶中加入孕甾-1,4,9(11),16-四烯-3,20-二酮(3.08g,0.01mol),四氢呋喃45毫升,N-溴代丁二酰亚胺(2.4g,0.013mol),28毫升0.64mol/L高氯酸水溶液,室温搅拌4小时。停止反应,往反应瓶中加入6毫升饱和亚硫酸钠溶液,减压浓缩除去四氢呋喃后加入200毫升水,搅拌1小时,析出固体,减压过滤,用100毫升水洗固体三次,真空干燥所得的固体用甲醇和二氯甲烷重结晶,得白色固体3.75g,收率为95%。mp:170℃(分解)。1H NMR(DMSO-d6):δ=1.15(s,3H),1.56(m,1H),1.69(s,3H),1.99(m,1H),2.05(m,2H),2.20(s,3H),2.22-2.40(m,5H),2.66-2.68(m,1H),4.55(s,1H),5.63(brs,1H),5.98(t,J=1.2Hz,1H),6.22(dd,J=1.6Hz,J=10Hz,1H),6.87(dd,J=1.2Hz,J=2.8Hz,1H),7.34(d,J=10Hz,1H)。MS:m/z=404(M+),406(M++2)。In the reaction flask, add pregna-1,4,9(11), 16-tetraene-3,20-dione (3.08g, 0.01mol), 45 milliliters of tetrahydrofuran, N-bromosuccinimide ( 2.4g, 0.013mol), 28ml of 0.64mol/L perchloric acid aqueous solution, stirred at room temperature for 4 hours. Stop the reaction, add 6 ml of saturated sodium sulfite solution to the reaction bottle, concentrate under reduced pressure to remove tetrahydrofuran, add 200 ml of water, stir for 1 hour, and precipitate a solid, filter under reduced pressure, wash the solid with 100 ml of water three times, dry the resulting solid with methanol Recrystallized with dichloromethane to obtain 3.75 g of white solid with a yield of 95%. mp: 170°C (decomposition). 1 H NMR (DMSO-d6): δ=1.15(s, 3H), 1.56(m, 1H), 1.69(s, 3H), 1.99(m, 1H), 2.05(m, 2H), 2.20(s, 3H), 2.22-2.40(m, 5H), 2.66-2.68(m, 1H), 4.55(s, 1H), 5.63(brs, 1H), 5.98(t, J=1.2Hz, 1H), 6.22(dd , J=1.6Hz, J=10Hz, 1H), 6.87 (dd, J=1.2Hz, J=2.8Hz, 1H), 7.34 (d, J=10Hz, 1H). MS: m/z = 404 (M + ), 406 (M + +2).
熔点由Büchi Melting Point B-540熔点仪测定,1HNMR由Bruker Avance DMX400核磁共振仪测定,质谱由GC-HP-5989质谱仪测定。The melting point was determined by a Büchi Melting Point B-540 melting point apparatus, the 1 HNMR was determined by a Bruker Avance DMX400 nuclear magnetic resonance instrument, and the mass spectrum was determined by a GC-HP-5989 mass spectrometer.
例2Example 2
在反应瓶中加入孕甾-1,4,9(11),16-四烯-3,20-二酮(3.08g,0.01mol),四氢呋喃45毫升,N-溴代乙酰胺(1.79g,0.013mol),28毫升0.64mol/L高氯酸水溶液,室温搅拌4小时。停止反应,往反应瓶中加入6毫升饱和亚硫酸钠溶液,减压浓缩除去四氢呋喃后加入200毫升水,搅拌1小时,析出固体,减压过滤,用100毫升水洗固体三次,真空干燥所得的固体用甲醇和二氯甲烷重结晶,得白色固体3.67g,收率为93%。In the reaction flask, add pregna-1,4,9(11), 16-tetraene-3,20-dione (3.08g, 0.01mol), 45 ml of tetrahydrofuran, N-bromoacetamide (1.79g, 0.013mol), 28 milliliters of 0.64mol/L perchloric acid aqueous solution, stirred at room temperature for 4 hours. Stop the reaction, add 6 ml of saturated sodium sulfite solution to the reaction bottle, concentrate under reduced pressure to remove tetrahydrofuran, add 200 ml of water, stir for 1 hour, and precipitate a solid, filter under reduced pressure, wash the solid with 100 ml of water three times, dry the resulting solid with methanol Recrystallized with dichloromethane to obtain 3.67 g of white solid with a yield of 93%.
例3Example 3
在反应瓶中加入孕甾-1,4,9(11),16-四烯-3,20-二酮(3.08g,0.01mol),二氧六环45毫升,N-溴代丁二酰亚胺(2.4g,0.013mol),28毫升0.64mol/L高氯酸水溶液,室温搅拌4小时。停止反应,往反应瓶中加入6毫升饱和亚硫酸钠溶液,减压浓缩除去四氢呋喃后加入200毫升水,搅拌1小时,析出固体,减压过滤,用100毫升水洗固体三次,真空干燥所得的固体用甲醇和二氯甲烷重结晶,得白色固体3.60g,收率为91%。In the reaction flask, add pregna-1,4,9(11), 16-tetraene-3,20-dione (3.08g, 0.01mol), 45 ml of dioxane, N-bromosuccinyl Imine (2.4 g, 0.013 mol), 28 ml of 0.64 mol/L perchloric acid aqueous solution, stirred at room temperature for 4 hours. Stop the reaction, add 6 ml of saturated sodium sulfite solution to the reaction bottle, concentrate under reduced pressure to remove tetrahydrofuran, add 200 ml of water, stir for 1 hour, and precipitate a solid, filter under reduced pressure, wash the solid with 100 ml of water three times, dry the resulting solid with methanol Recrystallized with dichloromethane to obtain 3.60 g of white solid with a yield of 91%.
例4Example 4
在反应瓶中加入孕甾-1,4,9(11),16-四烯-3,20-二酮(3.08g,0.01mol),二氧六环45毫升,N-溴代乙酰胺(1.79g,0.013mol),28毫升0.64mol/L高氯酸水溶液,室温搅拌4小时。停止反应,往反应瓶中加入6毫升饱和亚硫酸钠溶液,减压浓缩除去四氢呋喃后加入200毫升水,搅拌1小时,析出固体,减压过滤,用100毫升水洗固体三次,真空干燥所得的固体用甲醇和二氯甲烷重结晶,得白色固体3.65g,收率为92%。In the reaction flask, add pregna-1,4,9(11), 16-tetraene-3,20-dione (3.08g, 0.01mol), 45 milliliters of dioxane, N-bromoacetamide ( 1.79g, 0.013mol), 28ml of 0.64mol/L perchloric acid aqueous solution, stirred at room temperature for 4 hours. Stop the reaction, add 6 ml of saturated sodium sulfite solution to the reaction bottle, concentrate under reduced pressure to remove tetrahydrofuran, add 200 ml of water, stir for 1 hour, and precipitate a solid, filter under reduced pressure, wash the solid with 100 ml of water three times, dry the resulting solid with methanol Recrystallized with dichloromethane to obtain 3.65 g of white solid with a yield of 92%.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610052956 CN1908003A (en) | 2006-08-15 | 2006-08-15 | Method of synthesizing 9 alpha-bromine-11 beta-hydroxypregna-1,4,16-triene-3,20-diketone |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610052956 CN1908003A (en) | 2006-08-15 | 2006-08-15 | Method of synthesizing 9 alpha-bromine-11 beta-hydroxypregna-1,4,16-triene-3,20-diketone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1908003A true CN1908003A (en) | 2007-02-07 |
Family
ID=37699248
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610052956 Pending CN1908003A (en) | 2006-08-15 | 2006-08-15 | Method of synthesizing 9 alpha-bromine-11 beta-hydroxypregna-1,4,16-triene-3,20-diketone |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1908003A (en) |
-
2006
- 2006-08-15 CN CN 200610052956 patent/CN1908003A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5657052B2 (en) | Use of pregnane and androstane steroids for the manufacture of pharmaceutical compositions for the treatment of CNS diseases | |
| US10233210B2 (en) | Process for preparation of glucocorticoid steroids | |
| DE3783007T2 (en) | 9-ALPHA HYDROXYSTEROIDS, METHOD FOR THE PRODUCTION THEREOF AND METHOD FOR THE PRODUCTION OF THE CORRESPONDING 9 (11) -DEHYDRO DERIVATIVES. | |
| CN101223186A (en) | Process for the preparation of 3-oxo-pregn-4-en-21, 17-olides by metal-free oxidation of 17- (3-hydroxypropyl) -3, 17-dihydroxyandrostanes | |
| Nathansohn et al. | Steroids possessing nitrogen atoms. III. Synthesis of new highly active corticoids.[17α, 16α,-d] oxazolino steroids | |
| ES2351184T3 (en) | PROCEDURE FOR THE PRODUCTION OF 16.17 - [(CICLOHEXILMETILEN) BIS (OXIL)] - 11,21-DIHYDROXI-PREGNA-1,4-DIEN-3,20-DIONA OR ITS 21-ISOBUTIRATE THROUGH TRANSCETALIZATION. | |
| CN107400153A (en) | A kind of preparation method of hydrocortisone acetate | |
| CN102558273A (en) | Method for preparing fluticasone furoate | |
| CN1908003A (en) | Method of synthesizing 9 alpha-bromine-11 beta-hydroxypregna-1,4,16-triene-3,20-diketone | |
| BRPI0619428A2 (en) | Process 17α-cyanomethyl-17 (beta) -hydroxy-estra-4,9-diene-3-one for the synthesis thereof | |
| CN109438538A (en) | A kind of synthetic method of -17 beta-hydroxy -3- ketone of -17 Alpha-Methyl of Stanozolol intermediate androstane | |
| CN103772468A (en) | Preparation methods and purposes of Proellex(R)-V and intermediate of Proellex(R)-V | |
| CN104231025B (en) | A kind of estrone bulk drug impurity and preparation method thereof and the purposes as standard items | |
| KR20100063370A (en) | Method for preparing rocuronium bromide | |
| CN109134576B (en) | Method for synthesizing lithocholic acid by taking hyodeoxycholic acid as raw material | |
| CN106518939B (en) | Method for preparing Solithromycin compound | |
| EP1575983A1 (en) | 17.beta-[alpha-hydroxy]-esters of androstanes as intermediates for the preparation of 17.beta.-fluorinated-androstane esters | |
| CH494216A (en) | Process for the preparation of 6-aminomethyl-3,5-steroids bearing an etherified hydroxyl group in the 3-position | |
| DE2603545C3 (en) | New 16 a -Methyl-17 a - bromo-prednisolone- and prednisone derivatives and processes for their preparation | |
| CN120484042B (en) | A method for synthesizing HE3286 | |
| CN119529013B (en) | Synthesis method of Zu Lanuo dragon intermediate | |
| CN102040646A (en) | Synthetic process for preparing 6alpha-fluoro steroids by using NFTh fluorinating agent | |
| CN104292287A (en) | Synthesizing method of 17-ethinyl-16-ene steroid derivative | |
| CN104292288A (en) | Preparation method of 17-ethinyl-16-ene steroid derivative | |
| JPH036158B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |